Tag: Neuropharmacology

Study: Cannabidiol Induces ‘Rapid-Acting Antidepressant-Like Effects’

Cannabidiol (CBD) – a compound found in the cannabis plant – induces “rapid-acting antidepressant-like effects”, according to a new study being published in the April issue of the journal Neuropharmacology. “Cannabidiol (CBD), the main non-psychotomimetic component of marihuana, exhibits anxiolytic-like properties in many behavioural tests, although its potential for treating major depression has been poorly …

Continue reading

Cannabis May Improve Motor Symptoms, Stimulate Neuroprotective Processes In Those With Huntington’s Disease

A study published this month in the journal Neuropharmacology, and published online by the U.S. National Institute of Health, has found that prolonged administration of a compound meant to mimic the effects of cannabis can improve motor symptoms and stimulate neuroprotective processes in those with Huntington’s disease. “Huntington’s disease (HD) is a devastating neurodegenerative disease …

Continue reading

New Study Finds Cannabis May Have Neuroprotective Effects

A new study, published in the August edition of Neuropharmacology, has found that cannabis may serve as a neuroprotectant. Researchers from the University Hospital Puerta de Hierro Majadahonda, in Madrid, Spain, examined the effect of CBD when applied to a hypoxic-ischemic (HI) brain injury model (most common in instances such as cardiac arrest, when blood …

Continue reading

New Study Indicates Cannabis May Reduce Aggression, Improve Social Interactions

A new study published by the journal Neuropharmacology has found that cannabinoids may reduce aggression, and improve social interactions. For the study, researchers “examined the role of cannabinoid CB1 receptors (CB1r) in aggressive behavior”, and found that a compound meant to mimic THC (a prime compound of cannabis) “significantly decreased the aggression levels” of the mice …

Continue reading